Computer-Aided Drug Designing of Ocimum basilicum Compounds as Therapeutic Agents against RdRp of SARS-CoV2

Computer-Aided Drug Designing of Ocimum basilicum Compounds


  • Mehwish Shafiq Department of Biotechnology, Kinnaird College for Women, Lahore, Pakistan
  • Rashid Saif Decode Genomics, Punjab University Employees Housing Scheme, Lahore, Pakistan
  • Laraib Ali Department of Biotechnology, Kinnaird College for Women, Lahore, Pakistan
  • Tuba Ahmad Department of Biochemistry, Kinnaird College for Women, Lahore, Pakistan
  • Iram Anjum Department of Biotechnology, Kinnaird College for Women, Lahore, Pakistan
  • Anood Sohail Department of Biotechnology, Kinnaird College for Women, Lahore, Pakistan



SARS-Cov-2, COVID-19, Ocimum basilicum, Molecular Docking, Nevadensin


The prevailing situation of the World is challenging due to COVID-19 pandemic that is caused by SARS-CoV2.  Objectives: To combat with this emerging pandemic by reducing disease severity and infection, the need of hour is to develop an effective vaccine and antiviral candidates as therapeutic agents against SARS-CoV2. Methods: This study was developed for the identification of potential anti-viral agents, from Ocimum basilicum against RdRp of SARS-CoV2. In this concern, nevadensin, ursolic acid, β-Sesquiphellandren, apigenin, nerolidol, nonyl acetate and geranyl acetate were screened out of fifty-seven compounds from Ocimum basilicum based on their best docking scores. The docking results were also compared with already clinically used drugs (Remdesivir and Ribavirin) against the RdRp of SARS-CoV2. Molecular docking was performed using MOE software. The ADMET analysis and drug likeliness were also performed for all screened compounds by using admetSAR, pkCSM and SwissADME. Results: Cumulatively, the optimum binding energies of screened compounds indicated their potential for drug development against SARS-CoV2. It appears promising that nevadensin exhibited a good docking score and high binding affinity towards RdRp of SARS-CoV2. Therefore, it may represent the potential to inhibit COVID-19. Conclusion: Hence, Ocimum basilicum nutraceuticals could be effective therapeutic candidates for the treatment and prevention of COVID-19.


Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan, China. International journal of infectious diseases. 2020 Feb; 91: 264-6. doi: 10.1016/j.ijid.2020.01.009

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet. 2020 Feb; 395(10223): 507-13. doi: 10.1016/S0140-6736(20)30211-7

Tison GH, Avram R, Kuhar P, Abreau S, Marcus GM, Pletcher MJ, et al. Worldwide effect of COVID-19 on physical activity: a descriptive study. Annals of internal medicine. 2020 Nov; 173(9): 767-70. doi: 10.7326/M20-2665

Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Military medical research. 2020 Dec; 7(1): 1-23. doi: 10.1186/s40779-020-0233-6

Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International journal of antimicrobial agents. 2020 Mar; 55(3): 105924. doi: 10.1016/j.ijantimicag.2020.105924

Eastin C, Eastin T. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China: Dong Y, Mo X, Hu Y, et al. Pediatrics. 2020. Journal of Emergency Medicine. 2020 Apr; 58(4): 712-3. doi: 10.1016/j.jemermed.2020.04.006

Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a novel SARS-CoV-2. Gene reports. 2020 Jun; 19: 100682. doi: 10.1016/j.genrep.2020.100682

Astuti I. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020 Jul; 14(4): 407-12. doi: 10.1016/j.dsx.2020.04.020

Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020 Apr; 181(2): 281-92. doi: 10.1016/j.cell.2020.02.058

Chellapandi P and Saranya S. Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery. Medicinal Chemistry Research. 2020 Oct; 29(10): 1777-91. doi: 10.1007/s00044-020-02610-8

Sargunam P and Sridharan S. In-silico drug designing of novel morpholino based physcion drug candidate and investigation of inhibition effects on Covid-19 RNA dependent-RNA polymerase non structural protein 12 (Nsp 12) with ADMET study.

Tsai PH, Wang ML, Yang DM, Liang KH, Chou SJ, Chiou SH, et al. Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Journal of the Chinese Medical Association. 2020 Aug; 83(8): 725-32. doi: 10.1097/JCMA.0000000000000387

Huang J, Song W, Huang H, Sun Q. Pharmacological therapeutics targeting RNA-dependent RNA polymerase, proteinase and spike protein: from mechanistic studies to clinical trials for COVID-19. Journal of clinical medicine. 2020 Apr; 9(4). doi: 10.3390/jcm9041131

Rubab S, Hussain I, Khan BA, Unar AA, Abbas KA, Khichi ZH, et al. Biomedical Description of Ocimum basilicum L. Journal of Islamic International Medical College. 2017 Mar; 12(1): 59-67.

Gao Y, Yan L, Huang Y, Liu F, Zhao Y, Cao L, et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020 May; 368(6492): 779-82. doi: 10.1126/science.abb7498

Maurya VK, Kumar S, Prasad AK, Bhatt ML, Saxena SK. Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor. Virusdisease. 2020 Jun; 31: 179-93. doi: 10.1007/s13337-020-00598-8

Vidal-Limon A, Aguilar-Toalá JE, Liceaga AM. Integration of molecular docking analysis and molecular dynamics simulations for studying food proteins and bioactive peptides. Journal of Agricultural and Food Chemistry. 2022 Jan; 70(4): 934-43. doi: 10.1021/acs.jafc.1c06110

Henrich S, Feierberg I, Wang T, Blomberg N, Wade RC. Comparative binding energy analysis for binding affinity and target selectivity prediction. Proteins: Structure, Function, and Bioinformatics. 2010 Jan; 78(1): 135-53. doi: 10.1002/prot.22579

Aungst BJ. Optimizing oral bioavailability in drug discovery: an overview of design and testing strategies and formulation options. Journal of pharmaceutical sciences. 2017 Apr; 106(4): 921-9. doi: 10.1016/j.xphs.2016.12.002

Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports. 2017 Mar; 7(1). doi: 10.1038/srep42717



DOI: 10.54393/fbt.v2i02.5
Published: 2022-12-31

How to Cite

Shafiq, M., Saif , R., Ali, L., Ahmad, T., Anjum, I., & Sohail, A. (2022). Computer-Aided Drug Designing of Ocimum basilicum Compounds as Therapeutic Agents against RdRp of SARS-CoV2: Computer-Aided Drug Designing of Ocimum basilicum Compounds. Futuristic Biotechnology, 2(02), 19–23.



Orginal Articles